Nanjing Vishee Medical Technology Co Ltd
SSE:688580

Watchlist Manager
Nanjing Vishee Medical Technology Co Ltd Logo
Nanjing Vishee Medical Technology Co Ltd
SSE:688580
Watchlist
Price: 30.22 CNY 1.27% Market Closed
Market Cap: 2.9B CNY
Have any thoughts about
Nanjing Vishee Medical Technology Co Ltd?
Write Note
Section:
 

Relative Value

The Relative Value of one Nanjing Vishee Medical Technology Co Ltd stock under the Base Case scenario is 46.42 CNY. Compared to the current market price of 30.22 CNY, Nanjing Vishee Medical Technology Co Ltd is Undervalued by 35%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
46.42 CNY
Undervaluation 35%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

6.7
P/S
P/S
Price to Sales
6.7
vs History
50
vs Industry
24
Median 3Y
9.8
Median 5Y
7.1
Industry
2.3
Forward
5.7
More Details
25.1
P/E
P/E
Price to Earnings
25.1
vs History
40
vs Industry
30
Median 3Y
28.2
Median 5Y
23.4
Industry
23.1
Forward
17.3
More Details
23.1
P/OCF
P/OCF
Price to OCF
23.1
vs History
46
vs Industry
23
Median 3Y
32.3
Median 5Y
22.5
Industry
14.2
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
4
Median 3Y
-363.7
Median 5Y
-630.3
Industry
20.1
More Details
1.8
P/B
P/B
Price to Book Value
1.8
vs History
66
vs Industry
51
Median 3Y
2.6
Median 5Y
2.5
Industry
2.2
More Details
4.3
EV/S
EV/S
Enterprise Value to Sales
4.3
vs History
50
vs Industry
39
Median 3Y
6.7
Median 5Y
4.4
Industry
2.4
Forward
3.7
More Details
6.1
EV/GP
EV/GP
Enterprise Value to Gross Profit
6.1
vs History
48
vs Industry
50
Median 3Y
9.4
Median 5Y
6.1
Industry
5
More Details
18.7
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
18.7
vs History
44
vs Industry
32
Median 3Y
23.5
Median 5Y
16.8
Industry
12.7
Forward
12
More Details
18.7
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
18.7
vs History
44
vs Industry
37
Median 3Y
23.5
Median 5Y
16.8
Industry
17.1
Forward
11.4
More Details
14.9
EV/OCF
EV/OCF
Enterprise Value to OCF
14.9
vs History
46
vs Industry
38
Median 3Y
23.1
Median 5Y
14.3
Industry
14
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
6
Median 3Y
-273.3
Median 5Y
-390.1
Industry
18
More Details
2.7
EV/IC
EV/IC
Enterprise Value to IC
2.7
vs History
66
vs Industry
36
Median 3Y
6.9
Median 5Y
6.2
Industry
1.9
More Details

Multiples Across Competitors

Competitors Multiples
Nanjing Vishee Medical Technology Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Nanjing Vishee Medical Technology Co Ltd
SSE:688580
2.9B CNY 6.7 25.1 18.7 18.7
US
Abbott Laboratories
NYSE:ABT
199B USD 4.8 34.5 20 29.3
US
Intuitive Surgical Inc
NASDAQ:ISRG
191.3B USD 24.3 85.3 72.8 90.4
US
Stryker Corp
NYSE:SYK
141.3B USD 6.4 39.4 25.6 31
US
Boston Scientific Corp
NYSE:BSX
134.2B USD 8.4 74.8 34.3 49
IE
Medtronic PLC
NYSE:MDT
104.6B USD 3.2 24.4 13.6 19.3
US
Becton Dickinson and Co
NYSE:BDX
65.6B USD 3.3 38 15.7 28.2
DE
Siemens Healthineers AG
XETRA:SHL
58.1B EUR 2.6 31.2 17.7 25.8
US
Edwards Lifesciences Corp
NYSE:EW
44.5B USD 7.9 10.7 23.8 26.1
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
311.1B CNY 8.4 25.1 21.8 21.8
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
36.1B USD 1.8 21.6 13.5 16.7

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 210,800+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.